Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Annals of Surgery|December 14, 2022
Medical Assistance in Dying (MAiD) as a Source of Liver Grafts: Honouring the Ultimate GiftSamrat Ray, Alejandro Torres-Hernandez, Michael Sean Bleszynski, et al.
Annals of Surgery|July 23, 2024
Living Donor Availability Improves Patient Survival in a North American Center: An Intention-to-treat AnalysisZhihao Li, Owen Jones, Christian T J Magyar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 18, 2026
Simultaneous Islet-Kidney Transplantation as an Alternative for Patients Ineligible for Pancreas Transplant: Initial Experience at a North American Transplant CenterCatherine Parmentier, Xin Di Lin, Abdulmohsen Bakhsh, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Comparing outcomes of deceased-donor and living-donor liver transplants in patients with PVTZhihao Li, Owen Jones, Luckshi Rajendran, et al.
Hepatology Communications|September 17, 2021
The Detrimental Role of Regulatory T Cells in Nonalcoholic SteatohepatitisJanine Dywicki, Laura Elisa Buitrago-Molina, Fatih Noyan, et al.
Journal of Autoimmunity|November 11, 2015
Two separate mechanisms of enforced viral replication balance innate and adaptive immune activationNamir Shaabani, Vishal Khairnar, Vikas Duhan, et al.
Science Translational Medicine|June 27, 2014
HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humansFelix Bohne, María-Carlota Londoño, Carlos Benítez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2026
Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive TherapyTheresa Kirchner, George N Dalekos, Kalliopi Zachou, et al.
Transplantation|November 12, 2024
Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver TransplantationChristian T J Magyar, Sheron Perera, Luckshi Rajendran, et al.
Pageof 23